药明康德

This December marks WuXi AppTec’s 24th anniversary! For 24 years, our belief that “every drug can be made and every disease can be treated” has continued to inspire us as we look to the future with determination and optimism. Starting from a single laboratory, we have grown into a global enterprise with 32 R&D and manufacturing sites worldwide, dedicated to advancing breakthroughs in life-sciences. Thank you to our customers, partners, and global teams - your commitment to our mission of enabling transformative solutions has been the heartbeat of our success. Together, we’re not just imagining a healthier world - we are building it.

As we mark Thanksgiving in the United States, we wanted to extend our gratitude to our global teams for their dedication and to our customers worldwide for their continued trust and support. Together, we are driving innovation, bringing hope and advancements to patients, striving towards a healthier world. This season is a reminder of our shared goals and the positive impact we make together.   Happy #Thanksgiving to those in the United States!

We are proud to announce that WuXi AppTec has received a gold medal in the 2024 EcoVadis Sustainability Rating, placing us in the top 2% of all participating companies! This achievement reflects our commitment to sustainability and our ongoing efforts to integrate environmental and social responsibilities throughout our operations. Looking ahead, we will continue to advance #ESG efforts, support customers in delivering innovative therapies, and create a lasting, positive impact on the healthcare industry.  Read more: https://lnkd.in/ee26vAbR

Antimicrobial resistance (AMR) is one of the most critical global health challenges of the 21st century. The World Health Organization warns that by 2050, AMR could cause 10 million deaths annually, surpassing cancer as the leading cause of death. At WuXi AppTec, we are committed to supporting global efforts to address this issue. Learn more about AMR from leading experts at Wellcome Trust, AMR Action Fund, CARB-X, Roche, Massachusetts Institute of Technology. https://lnkd.in/efTmVm9m

Congratulations to our WuXi Chemistry facility in Couvet, Switzerland!  Incredible recognition for diligent work meeting our shared global #ESG responsibilities.

Thank you to those who attended our WuXi Night last week during BIO-Europe 2024 in Stockholm. The demand for new and better medicines remains unchanged. Let us look forward with hope and a shared commitment to transform more scientific discoveries into innovative therapies for patients, striving to our vision that “every drug can be made and every disease can be treated”.

We are honored to announce that WuXi AppTec has been ranked #1 in the global Life Sciences Tools & Services sector in the 2024 S&P Global Corporate Sustainability Assessment (CSA), as of November 11, 2024! We achieved a 2024 CSA score of 80 out of 100 points, an impressive 11-point increase over 2023. The company received full marks in 43 out of 102 areas evaluated in the CSA.   This achievement demonstrates WuXi AppTec’s success in enhancing our capability to address ESG-related risks and opportunities across our global operations. By embedding ESG initiatives at the core, we are contributing to a healthier and more sustainable world.   Stay tuned for more exciting updates! https://lnkd.in/efSma98c #ESG #Sustainability #CSA

Happy #WorldCitiesDay!   Our global presence spans diverse cities, each playing a vital role in advancing health innovation. Today, we celebrate not just the cities where we operate, but the incredible people who make it all possible.   Worldwide, our employees are sharing what they cherish about WuXi AppTec in their native languages. Their messages reflect our unwavering commitment to delivering life-saving treatments and making a meaningful impact for patients.   WuXi AppTec is a proud global community dedicated to advancing the future of healthcare.   Let's keep building a healthier world together.

Thank you, Frost & Sullivan, for awarding us the 2024 Global Contract Research, Development and Manufacturing Organization Company of the Year Award. This is a proud moment for us! This marks the 8th consecutive year that WuXi AppTec has received this award. We are deeply honored by the recognition, which underscores how we meet customers’ needs through our comprehensive #CRDMO model. By continuously enhancing our capabilities and capacity, we support seamless drug development from discovery to commercialization, enabling the industry to bring more groundbreaking therapies to patients around the world. https://lnkd.in/e-suw_fP

WuXi AppTec's 2024 Investor Day was an incredible success. I’m grateful to Florence Shi, Edward Hu and Minzhang Chen for organizing such an outstanding event. Each year, we must be sensitive to trends to embrace the future – adapting our capabilities to drive innovation and sustain development. By generating flow, understanding trends, and providing coordinated capabilities, we create significant value for our customers. To our investors and talented individuals around the company, your contributions and collaboration are invaluable as we continue to deliver for patients. https://lnkd.in/gkAvkFJE